Wen Jing Tang

Wen Jing Tang (温经汤, Wēn Jīng Tāng) is a classical Chinese herbal formula first recorded in the Jin Gui Yao Lue (金匮要略, Essentials from the Golden Cabinet) by Zhang Zhongjing (张仲景, c. 200 CE). The formula name literally translates to “Warming the Menses Decoction” or “Warm Channel Decoction” — Wen (温) means to warm, Jing (经) refers to the menstrual channels (Chong and Ren vessels), and Tang (汤) denotes the decoction format. In Japan, where it is a widely used Kampo medicine, it is known as Unkei-to.

In the TCM classification system, this formula belongs to the category of formulas that warm the channels and scatter Cold while nourishing blood and resolving stasis (wen jing san han, yang xue hua yu, 温经散寒, 养血化瘀). Its primary therapeutic strategy addresses a specific pathological constellation: when Cold accumulates in the Chong (Chong Mai, 冲脉) and Ren (Ren Mai, 任脉) vessels — the two extraordinary vessels most directly responsible for menstrual health and reproductive function — blood circulation is impeded. Over time, this Cold stagnation leads to blood stasis, while the underlying deficiency of Spleen Qi and blood fails to generate adequate nourishment for the vessels. The resulting pattern presents as a complex interweaving of Cold, deficiency, and stasis.

Within TCM education, Wen Jing Tang is considered one of the most important gynecological formulas and is a paradigmatic example of Zhang Zhongjing's approach to women's health. The formula is notable for its complexity: it simultaneously warms the channels (to dispel Cold), nourishes blood (to address deficiency), invigorates circulation (to resolve stasis), tonifies Qi (to support blood generation), transforms phlegm-dampness (to clear secondary obstruction), and clears Heat from the blood level (to address the Heat that can develop from prolonged stasis). This multi-layered approach reflects the intricate pathology of gynecological disorders as understood in the classical TCM framework.

In modern TCM clinical discussion, the formula is frequently mentioned in the context of dysmenorrhea (painful menstruation), amenorrhea (absence of menstruation), oligomenorrhea (infrequent menstruation), infertility, endometriosis, and menopausal complaints — all understood through the lens of Cold in the Chong and Ren vessels. It is worth noting that these correspondences between TCM patterns and modern biomedical conditions are conceptual analogies, not equivalences.

The formula appears in the Jin Gui Yao Lue (金匮要略, Essentials from the Golden Cabinet) in the chapter on women's miscellaneous diseases (妇人杂病脉证并治). The original text describes a woman with Cold in the lower abdomen, menstrual irregularities, and a feeling of fullness — the formula is indicated when Cold has accumulated in the Chong and Ren vessels, impairing the normal flow of blood and Qi. The classical presentation includes cold hands and feet, a parched mouth and lips, evening fever, and a dark, purplish tongue.

A notable feature of the original text is the description of “fifty days without menstruation” (经水不利五十天), which some commentators interpret as a reference to amenorrhea, while others suggest it describes a specific type of menstrual irregularity with prolonged cycles. This ambiguity has led to rich scholarly discussion about the formula's precise indications across centuries of TCM commentary, from the Tang dynasty's Tai Ping Hui Min He Ji Ju Fang to modern Chinese pharmacopeia commentary.

The formula also exists in another important version from Fu Qing Zhu's Fu Qing Zhu Nv Ke (傅青主女科, Fu Qing Zhu's Gynecology, 17th century), which contains a similar but not identical herb list. The Jin Gui Yao Lue version — which is the subject of this page — is considered the original and most authoritative. It is this version that has been most extensively studied in modern research and is the basis for the Japanese Kampo preparation Unkei-to, which is approved as an ethical pharmaceutical in Japan.

The following are traditional TCM pattern descriptions and are not modern medical diagnoses or treatment recommendations.

In the classical TCM framework, Wen Jing Tang addresses the interconnected pattern of Cold accumulating in the Chong and Ren vessels with blood deficiency and stasis. The primary traditional indications include:

• Menstrual disorders with Cold presentation — Late or scanty menstruation, amenorrhea, or irregular cycles accompanied by cold hands and feet, lower abdominal pain that improves with warmth, and a preference for warm drinks. The menstrual blood may be dark with clots.
• Lower abdominal Cold pain — A fixed, cold pain in the lower abdomen that may radiate to the lumbar region. The patient typically feels relief with the application of warmth and worsening with cold exposure.
• Infertility associated with Cold and stasis — In the TCM framework, Cold obstructing the Chong and Ren vessels can impair the uterus's ability to receive and retain the fetus. The formula is traditionally considered when infertility is accompanied by cold extremities, lower abdominal coldness, and a dark purplish tongue.
• Evening fever and dry lips and mouth — A distinctive feature noted in the original text, the patient may experience a slight temperature elevation in the evening along with dryness of the lips and mouth, reflecting the presence of Heat that has developed from prolonged blood stasis (blood stasis can generate Heat).
• Tongue and pulse signs — A dark purplish tongue body or a tongue with purplish spots (indicating blood stasis), possibly with a thin white coating (indicating Cold). The pulse is typically deep, thready, and choppy (chen xi se mai, 沉细涩脉) — deep (Cold), thready (deficiency), and choppy (stasis).

Modern TCM clinical discussion has expanded the formula's theoretical applications to include endometriosis (when presenting with Cold and stasis features), polycystic ovary syndrome (PCOS), menopausal symptoms with Cold presentation, and certain types of chronic pelvic pain. These expanded applications remain within the TCM pattern framework and have varying levels of supporting evidence.

The following composition reflects classical TCM literature references. Specific dosages are for educational reference only and are not dosage recommendations.

Formula Explanation (Fang Jie, 方解)

The architectural logic of Wen Jing Tang can be understood through four functional herb groups operating in concert:

• Gui Zhi (桂枝) — Chief Herb: Warms the Channels and Dispels Cold. Gui Zhi (Cinnamon Twig) is the principal herb and the foundation of the formula's channel-warming strategy. In TCM pharmacology, it is described as acrid, sweet, and warm, entering the Heart, Lung, and Bladder channels. It warms and unblocks the channels, dispels Cold, and promotes the free flow of Qi and blood through the Chong and Ren vessels. Its warming nature addresses the root cause of the pattern — Cold accumulation in the extraordinary vessels — while its blood-invigorating properties begin to address the resulting stasis. Cinnamaldehyde, its primary bioactive compound, has been studied for vasodilatory, anti-inflammatory, and analgesic properties.
• Chuan Xiong (川芎) + Dang Gui (当归) + Bai Shao (白芍) — Deputy Herbs: Nourish Blood and Resolve Stasis. These three herbs form the blood-regulating core of the formula. Dang Gui (Angelica Root) is the preeminent blood-nourishing herb in TCM, simultaneously nourishing blood and invigorating circulation — it both tonifies the deficiency and addresses the stasis. Chuan Xiong (Sichuan Lovage) is the premier herb for moving blood and Qi in the upper and lower body, particularly effective for menstrual pain and abdominal stagnation. Bai Shao (White Peony Root) nourishes blood and softens the Liver while providing an astringent quality that prevents excessive blood loss — a critical function given the blood-invigorating actions of Dang Gui and Chuan Xiong. Together, these three herbs ensure that blood is nourished (addressing deficiency) while circulation is restored (addressing stasis).
• Mu Dan Pi (牡丹皮) + Sheng Jiang (生姜) + Ban Xia (半夏) + Mai Men Dong (麦冬) + Ren Shen (人参) + E Jiao (阿胶) — Adjuvant Herbs: Multi-Targeted Support. This diverse group of six adjuvants provides a sophisticated array of supporting functions. Mu Dan Pi (Moutan Bark) clears Heat from the blood level and resolves stasis — its inclusion addresses the Heat that arises from prolonged blood stasis (as indicated by the evening fever in the original text). Sheng Jiang (Fresh Ginger) warms the Middle Jiao and harmonizes the Stomach, supporting the digestive function needed for blood generation. Ban Xia (Pinellia) transforms phlegm-dampness and directs rebellious Qi downward, addressing the fullness and nausea that can accompany the pattern. Mai Men Dong (Ophiopogon) nourishes Yin and moistens dryness, serving as a critical counterbalance to the many warming herbs — it protects Stomach Yin from the drying effects of Gui Zhi, Sheng Jiang, and Ban Xia. Ren Shen (Ginseng) strongly tonifies Spleen Qi, which is essential because Qi is the commander of blood — without adequate Qi, blood cannot circulate freely. E Jiao (Donkey-hide Gelatin) provides rich, gelatinous nourishment to both blood and Yin, consolidates the vessels, and helps stop abnormal bleeding.
• Gan Cao (甘草) — Envoy Herb: Harmonizes and Protects. Gan Cao (Licorice Root) harmonizes all the ingredients in this complex formula, ensuring that the warming, cooling, nourishing, drying, and moving actions work together without antagonizing each other. It also tonifies Spleen Qi to support blood generation and moderates the warming and drying properties of Gui Zhi, Sheng Jiang, and Ban Xia.

The overall therapeutic strategy can be summarized as “warming the channels while nourishing blood and resolving stasis” (wen jing san han, yang xue hua yu, 温经散寒, 养血化瘀). This elegant multi-layered approach — simultaneously addressing the Cold (warming), the deficiency (nourishing), and the stasis (invigorating) — exemplifies Zhang Zhongjing's sophisticated clinical reasoning for complex gynecological patterns where multiple pathological factors coexist.

Modern research on Wen Jing Tang has accumulated over several decades, with studies spanning preclinical pharmacology, clinical trials (particularly in Japan and Taiwan), and investigations into individual herb constituents. The formula is known as Unkei-to in Japanese Kampo medicine, where it is an approved pharmaceutical product. While the evidence base is growing, it remains largely preliminary. The following summaries reflect what individual studies have reported, not established clinical recommendations.

Level 1: Exact Formula Research

Studies investigating the complete classical formula as a whole preparation.

Dysmenorrhea and Uterine Contractility

Wen Jing Tang has been studied for its effects on dysmenorrhea through both clinical and in vitro approaches. A landmark 2003 study by Hsu CS et al. (PMID: 12916077) published in Phytotherapy Research investigated the effects of Wen Jing Tang on uterine contractility in vitro and found that the formula demonstrated antagonistic effects on both PGF2alpha- and oxytocin-induced uterine contractions, suggesting a potential mechanism for its traditional use in dysmenorrhea. Additionally, a 2014 nationwide prescription database study from Taiwan by Chen HY et al. (PMID: 24559826) found that Wen Jing Tang was the third most commonly prescribed formula for primary dysmenorrhea, used in approximately 20.5% of prescriptions — indicating its prominent role in clinical practice, though this observational data does not establish efficacy.

Polycystic Ovary Syndrome (PCOS) and Ovulation

Several clinical studies from Japan have investigated Unkei-to (the Kampo equivalent) for ovulatory dysfunction. A 2006 study by Ushiroyama T et al. (PMID: 16552830) published in American Journal of Chinese Medicine (n = 45 women with PCOS) reported that switching to Unkei-to from previously selected herbal preparations was associated with improvements in endocrine parameters and ovulation rates. Earlier, a 2001 study by Ushiroyama T et al. (PMID: 11396371) in Journal of Reproductive Medicine (n = 100) found that Unkei-to treatment for eight weeks significantly increased plasma estradiol levels by 43.5% and improved follicular growth in anovulatory women with high basal LH secretion. A 2003 study (PMID: 14696679) further confirmed FSH, LH, and estradiol increases after Unkei-to treatment in both hyper- and hypo-functioning amenorrheic patients. However, these studies were open-label, single-center, and lacked placebo controls.

Menopausal Symptoms and Peripheral Circulation

A 2006 randomized prospective study by Ushiroyama T et al. (PMID: 17163586) published in American Journal of Chinese Medicine compared Unkei-to with vitamin E for postmenopausal women with chilly sensations in the lower extremities. The randomized study found that Unkei-to improved peripheral blood flow and reduced cold sensation scores over an 8-week treatment period. A 2004 study by Koike K et al. (PMID: 15319700) in Clinical Neuropharmacology investigated Unkei-to as an adjunctive treatment to hormone replacement therapy for postmenopausal women with depressive symptoms and reported significant improvements in Zung's Self-Rating Depression Scale scores after three months of adjunctive Unkei-to therapy.

Infertility and Female Reproductive Health

A 2016 population-based cohort study from Taiwan by Hung YC et al. (PMID: 26986137) published in Medicine (Baltimore) investigated Chinese herbal products for female infertility using a nationwide database. The study found that Wen Jing Tang in combination with Dang Gui Shao Yao San was one of the most commonly used formula combinations (3.10% of prescriptions) for treating female infertility. While this demonstrates the formula's prominence in clinical practice, observational prescription data cannot establish causality or efficacy.

Endometriosis

A 2024 study by Hu X et al. (PMID: 39524878) published in Heliyon investigated the mechanism of Wen Jing Tang in the treatment of endometriosis using network pharmacology and experimental validation. The study identified potential molecular targets and pathways through which the formula might exert effects on endometriosis-related processes. While network pharmacology provides hypotheses for further investigation, these computational and preclinical findings cannot be directly extrapolated to clinical effectiveness in humans.

Level 2: Variant Research

Studies investigating modified versions of this formula or closely related combinations.

Combined Therapy with Clomiphene Citrate

A 1989 study by Yoshimoto Y et al. (PMID: 2633625) published in American Journal of Chinese Medicine investigated the effects of combined therapy with Wen Jing Tang and clomiphene citrate on anovulation in 16 infertile patients who had not responded to clomiphene citrate alone. The study reported that the combined therapy appeared to improve ovulation rates in clomiphene-resistant patients. While intriguing, this was a very small, uncontrolled study and the findings remain preliminary.

Level 3: Family Research

Studies investigating formulas in the same therapeutic family (channel-warming, blood-nourishing, and stasis-resolving category).

Related Blood-Nourishing and Stasis-Resolving Formulas

Research on formulas from the same therapeutic family provides complementary context. Gui Zhi Fu Ling Wan (桂枝茯苓丸), which shares the strategy of warming and resolving stasis, has been studied more extensively for endometriosis and uterine fibroids. A systematic review of Chinese herbal medicine for endometriosis found that blood-invigorating and stasis-resolving formulas (the family to which Wen Jing Tang belongs) were the most commonly studied category, with several trials reporting improvements in pain scores. While the formulas differ in composition, the shared therapeutic principle suggests biological plausibility, but the evidence remains preliminary.

Level 4: Ingredient-Related Research

Studies investigating individual herbs or compounds from this formula — findings may not reflect the complete formula's effects.

Gui Zhi (Cinnamomi Ramulus) and Dang Gui (Angelica sinensis)

Gui Zhi contains cinnamaldehyde as its primary bioactive compound, which has demonstrated vasodilatory, anti-inflammatory, analgesic, and anticoagulant properties in preclinical studies. Cinnamaldehyde has been shown to modulate TRPA1 and TRPV1 ion channels involved in pain perception, which may be relevant to the formula's traditional use for dysmenorrhea. Dang Gui contains ligustilide and ferulic acid as primary bioactive compounds, which have demonstrated anti-inflammatory, antioxidant, and antispasmodic effects. A systematic review of Dang Gui for primary dysmenorrhea found that studies reported potential benefits for pain reduction. However, individual herb findings cannot be directly extrapolated to the clinical effectiveness of the complete formula in humans.

Chuan Xiong (Ligusticum chuanxiong) and Bai Shao (Paeonia lactiflora)

Chuan Xiong contains ligustilide and tetramethylpyrazine (TMP) as primary bioactive compounds, which have demonstrated vasodilatory, antiplatelet, and neuroprotective effects in preclinical studies. TMP has been studied for its ability to inhibit platelet aggregation and improve microcirculation. Bai Shao contains paeoniflorin, which has demonstrated anti-inflammatory, analgesic, and muscle-relaxant effects in animal models. Paeoniflorin's mechanism may involve GABAergic modulation and calcium channel regulation, which could contribute to uterine muscle relaxation. These individual herb findings provide pharmacological context but cannot be directly extrapolated to the complete formula's effects.

Pharmacological Mechanisms (Preclinical Summary)

Collectively, the bioactive compounds identified across the herbs in Wen Jing Tang have demonstrated the following mechanisms in preclinical studies: vasodilation and improved microcirculation (cinnamaldehyde, ligustilide, TMP), uterine smooth muscle relaxation via calcium channel modulation (paeoniflorin, ligustilide), anti-inflammatory activity via NF-kappa B and COX-2 inhibition (cinnamaldehyde, ferulic acid, paeoniflorin), anticoagulant and antiplatelet effects (ligustilide, TMP, ferulic acid), estrogen-modulating activity (ferulic acid, several constituents), analgesic effects via TRP channel modulation (cinnamaldehyde, TMP), and immunomodulatory effects (paeoniflorin, glycyrrhizin). However, these isolated compound findings cannot be directly extrapolated to the clinical effectiveness of the complete formula in humans.

Overall Evidence Limitations

Key limitations of the existing evidence base include: most clinical studies were conducted in single centers in Japan or Taiwan with small sample sizes; the Japanese studies were open-label and lacked placebo controls; few studies compared the formula against established standard therapies with adequate power; many studies used the Japanese Kampo standard Unkei-to, which may differ in herb preparation and quality from Chinese TCM decoctions; long-term safety data are absent; there is a lack of high-quality, large-scale systematic reviews and meta-analyses specifically focused on Wen Jing Tang; and the gap between preclinical pharmacological findings (often promising) and clinical evidence (often inconclusive) remains substantial. As a result, the evidence does not establish efficacy for any specific condition.